Search Results - "Almeida, Sandro Soares de"
-
1
Effect of the ACTN-3 gene polymorphism on functional fitness and executive function of elderly
Published in Frontiers in aging neuroscience (09-09-2022)“…During aging, physical integrity and cognitive abilities, especially executive function, become compromised, directly influencing the quality of life of the…”
Get full text
Journal Article -
2
Association between ACTN3 (R577X), ACE (I/D), BDKRB2 (-9/+9), and AGT (M268T) polymorphisms and performance phenotypes in Brazilian swimmers
Published in BMC sports science, medicine & rehabilitation (19-02-2024)“…The influence of genetic polymorphisms on athletic performance has been widely explored. This study investigated the interactions between the polymorphisms…”
Get full text
Journal Article -
3
Behavioural effects of the ACE insertion/deletion polymorphism in Alzheimer's disease depend upon stratification according to APOE-ϵ4 carrier status
Published in Cognitive neuropsychiatry (01-07-2021)“…Introduction: The inherited risk of late-onset Alzheimer's disease (AD) is genetically determined. We aimed to examine associations of genetic variants of APOE…”
Get full text
Journal Article -
4
Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19
Published in Journal of physical activity & health (01-07-2024)“…To evaluate the influence of previous physical activity (PA) during childhood, adolescence, and current PA practice on the production of antibodies and…”
Get more information
Journal Article -
5
Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease
Published in Journal of Alzheimer's disease (01-01-2018)“…Lifetime risk factors for cognitive and functional decline in Alzheimer's disease (AD) are not fully understood, and were prospectively evaluated in patients…”
Get more information
Journal Article -
6
Equilíbrio e preocupação com quedas em idosas que praticam exercícios resistidos e aeróbio
Published in Educación Física y Ciencia (01-08-2022)“…A prática regular de exercício físico tem sido considera uma conduta eficiente para melhorar o equilíbrio de idosos. Porém, não está muito claro se os…”
Get full text
Journal Article -
7
APOE ε4 Carrier Status as Mediator of Effects of Psychotropic Drugs on Clinical Changes in Patients With Alzheimer's Disease
Published in The journal of neuropsychiatry and clinical neurosciences (01-10-2022)“…Neuropsychiatric syndromes have been associated with memory dysfunction and risk of and earlier onset of dementia, but how psychotropic drugs affect clinical…”
Get full text
Journal Article -
8
GRIN2B genotypes and APOE haplotypes affect the age at onset of Alzheimer’s dementia as well as variations in dementia staging according to the use of Memantine
Published in Alzheimer's & dementia (01-12-2023)“…Background Memantine antagonizes the N‐methyl‐D‐aspartate (NMDA) type of glutamate receptor leading to possible behavioral improvement and a synergistic effect…”
Get full text
Journal Article -
9
Polymorphism of the bradykinin type 2 receptor gene modulates blood pressure profile and microvascular function in prepubescent children
Published in Peptides (New York, N.Y. : 1980) (01-03-2021)“…•BDKRB2 + 9/−9 polymorphism is located in the regulatory region of the exon 1.•High cardiometabolic risk is associated with BDKRB2 + 9/−9 genotypes.•BDKRB2 +…”
Get full text
Journal Article -
10
Differential performance of cerebrospinal fluid biomarker ratios and formulas to discriminate dementia with Lewy bodies from Alzheimer’s dementia and cognitively healthy people reflects high level of amyloidosis across dementia syndromes
Published in Alzheimer's & dementia (01-12-2023)“…Background Neurodegeneration is a common hallmark of all dementia syndromes, whereas cerebrospinal fluid amyloid‐β may reflect amyloidosis both in Alzheimer’s…”
Get full text
Journal Article -
11
Biofluid activity and levels of the angiotensin‐converting enzyme may translate into distinct neuropsychiatric symptoms associated with cerebrospinal fluid amyloid‐beta effects and tauopathy in dementia with Lewy bodies and Alzheimer’s dementia
Published in Alzheimer's & dementia (01-12-2023)“…Background Amyloid‐β‐degrading enzymes such as the angiotensin‐converting enzyme (ACE‐1) might be surrogates of the amyloid‐β load in the brain potentially…”
Get full text
Journal Article -
12
Pharmacogenetics of angiotensin modulators according to APOE -ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer's disease
Published in Acta neuropsychiatrica (01-12-2023)“…In Alzheimer's disease (AD), angiotensin II receptor blockers (ARBs) could reduce cerebrovascular dysfunction, while angiotensin-converting enzyme inhibitors…”
Get more information
Journal Article -
13
Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults
Published in Neuromolecular medicine (01-11-2024)“…Clinical distinction between dementia with Lewy bodies (DLB) and late-onset Alzheimer’s disease (AD) is difficult, while several features might affect the…”
Get full text
Journal Article -
14
Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease
Published in Aging clinical and experimental research (01-08-2023)“…Aim To explore associations of cerebrospinal fluid biomarkers of neurodegeneration and amyloidosis with caregiver burden, cognition and functionality in…”
Get full text
Journal Article -
15
-
16
GRIN2A GENOTYPES AND APOE HAPLOTYPES AFFECT THE AGE AT ONSET OF ALZHEIMER’S DEMENTIA BUT NOT FUNCTIONAL OR COGNITIVE RESPONSE TO MEMANTINE
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
17
-
18
P3‐282: APOE‐DEPENDENT PSYCHOTROPIC EFFECTS OVER CLINICAL CHANGES IN ALZHEIMER'S DISEASE DEMENTIA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
19
APOE-DEPENDENT PSYCHOTROPIC EFFECTS OVER CLINICAL CHANGES IN ALZHEIMER’S DISEASE DEMENTIA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article -
20
COGNITIVE CHANGES ARE PHARMACOGENETICALLY MEDIATED BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH ALZHEIMER’S DISEASE DEMENTIA
Published in Alzheimer's & dementia (01-07-2018)Get full text
Journal Article